Сytokine markers for different variants of sclerotic lichen in women

Our work was aimed for studying the role of systemic of IL-23 and IL-20 levels in different clinical variants of sclerotic lichen in women. The study was based on results of clinical data (anamnesis, examination, palpation, vulvoscopy) and immunological studies (determination of IL-20 and IL-23 cyto...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: E. V. Kolesnikova, A. V. Zharov, I. A. Kharitonova, Yu. S. Mizina, S. V. Fedak
Formato: article
Lenguaje:RU
Publicado: SPb RAACI 2020
Materias:
Acceso en línea:https://doaj.org/article/4c7b9dbb4d024ed79b733e45261d77c2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4c7b9dbb4d024ed79b733e45261d77c2
record_format dspace
spelling oai:doaj.org-article:4c7b9dbb4d024ed79b733e45261d77c22021-11-18T08:03:49ZСytokine markers for different variants of sclerotic lichen in women1563-06252313-741X10.15789/1563-0625-CMF-1864https://doaj.org/article/4c7b9dbb4d024ed79b733e45261d77c22020-05-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/1864https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XOur work was aimed for studying the role of systemic of IL-23 and IL-20 levels in different clinical variants of sclerotic lichen in women. The study was based on results of clinical data (anamnesis, examination, palpation, vulvoscopy) and immunological studies (determination of IL-20 and IL-23 cytokines in peripheral blood) in the patients with sclerotic lichen (114 patients aged 42.5±15.1 years). Group I included patients with atrophic variant of sclerotic lichen (n = 58); group II, with sclerotic variant of sclerotic lichen (n = 34). Group III included women with a sclero-atrophic variant of this disorder (n = 22). The control group consisted of conditionally healthy women without present, or previously documented vulvar pathology (30 persons). Criteria for inclusion were as follows: women 20 to 60 years old, the presence of a benign vulvar disease, absence of treatment with immunotropic drugs over past year. Exclusion criteria: presence of viral infection (HPV, HSV), detection of STI, presence of acute inflammatory process (including vulvitis and vaginitis), cancer diagnosis, symptoms of autoimmune disorders, pregnancy, and the patient’s reluctance to participate in the study.Predominant increase of IL-23 was revealed in all clinical groups of the examined patients, the most pronounced increase (2.7 times) was in severe sclerotic lichen (p < 0.0001). IL-23 concentration in the 2nd clinical group corresponded to the reference age-matched values. There was a significant increase in the blood content of IL-20 in subgroup 2.2 of the patients with sclerotic lichen (p < 0.0001), as well as in patients from group 3 with a mixed clinical course of its disorder (p < 0.0001). Meanwhile, the absence of pronounced vulvar tissue sclerosis in sclerotic variant of sclerotic lichen (subgroup 2.1) was accompanied only by a tendency for increased IL-20 concentration (p = 0.502), and only a trend for decrease in atrophic variant of sclerotic lichen (p = 0.288). In general, analysis of these data presumes a significant role of IL-20 and IL-23 in pathogenesis of sclerotic lichen in women. The cytokine assays in various clinical variants of this vulvar disorder may provide additional differential diagnostics (IL-20), and to assess severity of atrophic and sclerotic changes in vulvar tissues (IL-23) in women with sclerotic lichen.E. V. KolesnikovaA. V. ZharovI. A. KharitonovaYu. S. MizinaS. V. FedakSPb RAACIarticleсytokinesvulvasclerotic lihenatrophic liheninterleukinsImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 22, Iss 3, Pp 551-556 (2020)
institution DOAJ
collection DOAJ
language RU
topic сytokines
vulva
sclerotic lihen
atrophic lihen
interleukins
Immunologic diseases. Allergy
RC581-607
spellingShingle сytokines
vulva
sclerotic lihen
atrophic lihen
interleukins
Immunologic diseases. Allergy
RC581-607
E. V. Kolesnikova
A. V. Zharov
I. A. Kharitonova
Yu. S. Mizina
S. V. Fedak
Сytokine markers for different variants of sclerotic lichen in women
description Our work was aimed for studying the role of systemic of IL-23 and IL-20 levels in different clinical variants of sclerotic lichen in women. The study was based on results of clinical data (anamnesis, examination, palpation, vulvoscopy) and immunological studies (determination of IL-20 and IL-23 cytokines in peripheral blood) in the patients with sclerotic lichen (114 patients aged 42.5±15.1 years). Group I included patients with atrophic variant of sclerotic lichen (n = 58); group II, with sclerotic variant of sclerotic lichen (n = 34). Group III included women with a sclero-atrophic variant of this disorder (n = 22). The control group consisted of conditionally healthy women without present, or previously documented vulvar pathology (30 persons). Criteria for inclusion were as follows: women 20 to 60 years old, the presence of a benign vulvar disease, absence of treatment with immunotropic drugs over past year. Exclusion criteria: presence of viral infection (HPV, HSV), detection of STI, presence of acute inflammatory process (including vulvitis and vaginitis), cancer diagnosis, symptoms of autoimmune disorders, pregnancy, and the patient’s reluctance to participate in the study.Predominant increase of IL-23 was revealed in all clinical groups of the examined patients, the most pronounced increase (2.7 times) was in severe sclerotic lichen (p < 0.0001). IL-23 concentration in the 2nd clinical group corresponded to the reference age-matched values. There was a significant increase in the blood content of IL-20 in subgroup 2.2 of the patients with sclerotic lichen (p < 0.0001), as well as in patients from group 3 with a mixed clinical course of its disorder (p < 0.0001). Meanwhile, the absence of pronounced vulvar tissue sclerosis in sclerotic variant of sclerotic lichen (subgroup 2.1) was accompanied only by a tendency for increased IL-20 concentration (p = 0.502), and only a trend for decrease in atrophic variant of sclerotic lichen (p = 0.288). In general, analysis of these data presumes a significant role of IL-20 and IL-23 in pathogenesis of sclerotic lichen in women. The cytokine assays in various clinical variants of this vulvar disorder may provide additional differential diagnostics (IL-20), and to assess severity of atrophic and sclerotic changes in vulvar tissues (IL-23) in women with sclerotic lichen.
format article
author E. V. Kolesnikova
A. V. Zharov
I. A. Kharitonova
Yu. S. Mizina
S. V. Fedak
author_facet E. V. Kolesnikova
A. V. Zharov
I. A. Kharitonova
Yu. S. Mizina
S. V. Fedak
author_sort E. V. Kolesnikova
title Сytokine markers for different variants of sclerotic lichen in women
title_short Сytokine markers for different variants of sclerotic lichen in women
title_full Сytokine markers for different variants of sclerotic lichen in women
title_fullStr Сytokine markers for different variants of sclerotic lichen in women
title_full_unstemmed Сytokine markers for different variants of sclerotic lichen in women
title_sort сytokine markers for different variants of sclerotic lichen in women
publisher SPb RAACI
publishDate 2020
url https://doaj.org/article/4c7b9dbb4d024ed79b733e45261d77c2
work_keys_str_mv AT evkolesnikova sytokinemarkersfordifferentvariantsofscleroticlicheninwomen
AT avzharov sytokinemarkersfordifferentvariantsofscleroticlicheninwomen
AT iakharitonova sytokinemarkersfordifferentvariantsofscleroticlicheninwomen
AT yusmizina sytokinemarkersfordifferentvariantsofscleroticlicheninwomen
AT svfedak sytokinemarkersfordifferentvariantsofscleroticlicheninwomen
_version_ 1718422346571710464